%0 Journal Article
%T Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of Olaparib, a Poly (ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients With BRCA1 or BRCA2 Mutations and Recurrent Ovarian Cancer
%A Kaye, Stan B.
%A Lubinski, Jan
%A Matulonis, Ursula
%A Ang, Joo Ern
%A Gourley, Charlie
%A Karlan, Beth Y.
%A Amnon, Amit
%A Bell-McGuinn, Katherine M.
%A Chen, Lee-May
%A Friedlander, Michael
%A Safra, Tamar
%A Vergote, Ignace
%A Wickens, Mark
%A Lowe, Elizabeth S.
%A Carmichael, James
%A Kaufman, Bella
%J Journal of Clinical Oncology
%V 30
%N 4
%P 372-379
%@ 0732-183X
%D 2012-02-01
%I Wolters Kluwer
%~ DeepDyve